APA (7th ed.) Citation

Cuisset, T., Cayla, G., Quilici, J., Pankert, M., Deharo, P., Bonnet, G., . . . Alessi, M. (2013). Off-label use of prasugrel in stable coronary artery disease is associated with greater degree of platelet inhibition compared with use after acute coronary syndrome. International Journal of Cardiology, 168(3), 2988. https://doi.org/10.1016/j.ijcard.2013.04.052

Chicago Style (17th ed.) Citation

Cuisset, Thomas, et al. "Off-label Use of Prasugrel in Stable Coronary Artery Disease Is Associated with Greater Degree of Platelet Inhibition Compared with Use After Acute Coronary Syndrome." International Journal of Cardiology 168, no. 3 (2013): 2988. https://doi.org/10.1016/j.ijcard.2013.04.052.

MLA (9th ed.) Citation

Cuisset, Thomas, et al. "Off-label Use of Prasugrel in Stable Coronary Artery Disease Is Associated with Greater Degree of Platelet Inhibition Compared with Use After Acute Coronary Syndrome." International Journal of Cardiology, vol. 168, no. 3, 2013, p. 2988, https://doi.org/10.1016/j.ijcard.2013.04.052.